Xeris Biopharma Announces Private Exchange of Convertible Notes

Key Takeaway: Xeris Biopharma has announced a private exchange of convertible notes. The details regarding the terms of the exchange and its implications for the company are not specified in the article. This move may impact the company's financial strategy moving forward, but further information is needed for a comprehensive analysis.